EFFECTS OF POSTOPERATIVE DILTIAZEM PROPHYLAXIS FOR THE PREVENTION OF ATRIAL FIBRILLATION IN PATIENTS UNDERGOING THORACOABDOMINAL ESOPHAGECTOMY: A RETROSPECTIVE COHORT STUDY

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00016631

Enrollment

167

Registered

2019-01-31

Start date

2016-10-24

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I48.9

Interventions

Group 1: postoperative Standard care plus Dilzem prophylaxis for 14 days Group 2: postoperative standard care alone

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: thoracoabdominal Esophagusresection

Exclusion criteria

Exclusion criteria: incomplete data sets

Design outcomes

Primary

Measure	Time frame
Atrial Fibrillation within the first 90 days after surgery	—

Secondary

Measure	Time frame
Bradykardia, Hypotension; 30 day mortality,	—

Countries

Germany

Contacts

Public ContactMarcel Hochreiter

Universitätsklinik HeidelbergKlinik für Anästhesiologie

marcel.hochreiter@med.uni-heidelberg.de06221-5639445

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026